Manandhar, N. R., G. K. Kayashta, and P. K. Acharya. “Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study”. Journal of Patan Academy of Health Sciences, vol. 5, no. 1, June 2018, pp. 47-56, doi:10.3126/jpahs.v5i1.24042.